Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, May 17 2018

Full Issue

Vermont Legalizes Importation Of Drugs From Canada, But HHS Still Has To Approve Plan

The Trump administration has been vocal about its opposition to importing drugs from foreign countries as a way to lower costs, with HHS Secretary Alex Azar calling it a "gimmick."

The Associated Press: Vermont Positioned For Cheaper Canadian Prescription Drugs

Vermont has become the first state to create a program to import more affordable prescription drugs from Canada. But it's unclear whether it will happen because it needs federal approval and the White House hasn't endorsed it. Republican Gov. Phil Scott said Wednesday the law would likely reduce costs for Vermonters, although he's unsure whether it will get federal approval. (5/16)

The Hill: Vermont Becomes First State To Allow Imported Drugs From Canada 

Proponents of the law, which has been opposed by President Trump's health officials as well as pharmaceutical companies, believe it will help fight rising drug prices. It was widely supported in Vermont's Democratic-controlled state legislature. The law must still be certified by the Department of Health and Human Services (HHS). (Roubein and Seipel, 5/16)

Politico: Vermont Becomes First State To Permit Drug Imports From Canada

A spokeswoman for Scott said he signed the bill Wednesday morning. The measure had overwhelming support in the Democratic-controlled legislature and is one of the most aggressive attempts by a state to tackle rising drug prices that critics say are crippling state finances. Its enactment also puts the Trump administration in a bind after the rollout of a highly anticipated plan for tackling rising drug costs. HHS still has to certify Vermont’s program. (Pradhan, 5/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, June 15
  • Friday, June 12
  • Thursday, June 11
  • Wednesday, June 10
  • Tuesday, June 9
  • Monday, June 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF